Product Description
ONO Pharm is developing ONO-1110 as a treatment for pain. (Sourced from: https://uk.ono-pharma.com/pipeline)
Mechanisms of Action: Endocannabinoid Regulator
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Company: Ono Pharmaceutical Co.,LTD
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: Japan
Active Clinical Trial Count: 13
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Cystitis, Interstitial|Depressive Disorder, Major|Fibromyalgia|Generalized anxiety disorder|Neuralgia, Postherpetic|Phobia, Social
Phase 1: Healthy Volunteers
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT06752590 |
ONO-1110-05 | P2 |
Active, not recruiting |
Fibromyalgia |
2026-07-01 |
12% |
2026-03-26 |
Primary Endpoints|Start Date|Treatments|Trial Status |
NCT06708416 |
ONO-1110-04 | P2 |
Active, not recruiting |
Neuralgia, Postherpetic |
2026-06-30 |
12% |
2026-03-03 |
Primary Endpoints|Treatments|Trial Status |
jRCT2031240578 |
jRCT2031240578 | P2 |
Not yet recruiting |
Generalized anxiety disorder |
2026-10-31 |
12% |
||
NCT06805565 |
ONO-1110-08 | P2 |
Active, not recruiting |
Phobia, Social |
2026-10-31 |
12% |
2026-02-21 |
Primary Endpoints|Treatments|Trial Status |
NCT06752603 |
ONO-1110-06 | P2 |
Active, not recruiting |
Cystitis, Interstitial |
2026-09-01 |
12% |
2026-04-01 |
Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments|Trial Status |
NCT06792136 |
ONO-1110-07 | P2 |
Active, not recruiting |
Depressive Disorder, Major |
2026-08-31 |
12% |
2026-02-21 |
Primary Endpoints|Treatments|Trial Status |
jRCT2071240014 |
jRCT2071240014 | P1 |
Recruiting |
Healthy Volunteers |
2024-11-30 |
|||
jRCT2031240577 |
jRCT2031240577 | P2 |
Not yet recruiting |
Depressive Disorder, Major |
2026-08-31 |
12% |
||
jRCT2071230063 |
jRCT2071230063 | P1 |
Not yet recruiting |
Healthy Volunteers |
2024-09-30 |
|||
jRCT2071220100 |
jRCT2071220100 | P1 |
Recruiting |
Healthy Volunteers |
2024-06-30 |
|||
jRCT2031240522 |
jRCT2031240522 | P2 |
Not yet recruiting |
Fibromyalgia |
2026-09-30 |
12% |
||
jRCT2031240558 |
jRCT2031240558 | P2 |
Not yet recruiting |
Cystitis, Interstitial |
2026-08-31 |
12% |
||
jRCT2031240504 |
jRCT2031240504 | P2 |
Recruiting |
Neuralgia, Postherpetic |
2026-08-31 |
12% |
Recent News Events
Date |
Type |
Title |
|---|